“Risk-Based Optimization Or Clinical Supply Forecasting? The Impact On Clinical Trial Supply Planning”
Our webinar at a glance:
Clinical supply optimization and clinical supply forecasting are often confused with one another, but mixing up the two approaches can bring dangerous results when managing a clinical supply chain.
Clinical trial optimization that is risk-based delivers many benefits, including ensuring 100% patient service levels and more efficient planning. It also brings information for fact-based decision making to the table in comparison with clinical supply forecasting tools.
In order to bring real efficiency while keeping patients safe, the only answer is risk-based optimization.
The N-SIDE Suite for Clinical Trials, offers an end-to-end optimization solution to help you in the optimization, planning, implementation and monitoring of your clinical trials.
It is the only system that uses overage as an output while allowing constant risk assessment throughout all stages of the Clinical Supply Chain.
With this webinar you will:
- Learn how to identify the differences between risk-based optimization and forecasting for clinical supply chain and manufacturing planning
- Discover how clinical trial optimization can reduce drug waste & budgets, while achieving 100% service level and accelerated timelines
- See real-life case studies demonstrating the impact of risk-based optimization vs. forecasting
Head of Solutions Adoption, Life Sciences
Amaury Jeandrain is an expert in Clinical trial supply and manufacturing optimization. He started his career in clinical supply chain working for a CMO before joining N-SIDE. In his 5 years of experience at N-SIDE, Amaury supported the optimization of hundreds of trials and programs from different indications and pharmaceutical companies, providing services ranging from risk-based optimization to clinical trial design and solving drug supply shortage problems. Amaury now leads a group of consultants, focusing on the Adoption N-SIDE’s solutions.
Senior Expert, Life Sciences
Cyrille Lefèvre has been working on the optimization of end-to-end clinical supplies with N-SIDE for more than 8 years. He has experience advising both large and small pharma for the forecasting and optimization of their clinical trials for all phases and through multiple therapeutic areas. Cyrille also has extensive experience training teams focusing on strategic planning and improving IRT resupply algorithms and the way they are used.